Accueil/Actions/VRDN

VRDN

USD

Viridian Therapeutics Inc. Common Stock

$22.550-0.170 (-0.748%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$22.720

Haut

$23.050

Bas

$22.140

Volume

4.98M

Fondamentaux de l'Entreprise

Capitalisation Boursière

2.1B

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

1.03M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $9.9Actuel $22.550Haut $27.2

Actualités Connexes

4 nov. 2025 · 10:20

Analyst Upgrades

BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target

BTIG analyst Julian Harrison reiterates Viridian Therapeutics with a Buy and maintains $61 price target.

BTIG Reiterates Buy on Viridian Therapeutics, Maintains $61 Price Target

3 nov. 2025 · 12:01

BusinessWire

Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease

- BLA for veligrotug successfully submitted to the U.S. Food and Drug Administration (FDA) in late October following recent consultation with the agency - - Veligrotug's Breakthrough Therapy Designation supports

Viridian Therapeutics Announces Successful October Submission of Biologics License Application (BLA) to U.S. FDA for Veligrotug in Thyroid Eye Disease

Actions Connexes

RDW

Redwire Corporation

NASDAQ

Military/Govern...

AGNCL

AGNC Investment Corp. Depositary Shares Each Representing a 1/1000th Interest in a Share of 7.75% Series G Fixed-Rate Reset Cumulative Redeemable Preferred Stock

NASDAQ

Fiducies de pla...